Sign in

CIK 0001583648

  • Non-accelerated filer
  • Smaller reporting company

PALVELLA THERAPEUTICS, INC.

Sign in to watch
Ticker
PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
300784346
Phone
+1 484-253-1461
Business address
353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
Former names
PIERIS PHARMACEUTICALS, INC., Marika Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,725,861
in 7 filings, $11.7M under 10b5-1 plans

Net −$11,725,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 9 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-01-25 Barbier Ann Director Grant or award · Stock Option (right to buy) +20,000 20,000
2019-01-25 GERAGHTY JAMES A Director Grant or award · Stock Option (right to buy) +25,000 25,000
2018-10-25 Richman Michael Director Grant or award · Stock Option (right to buy) +3,829 $2.86 $11K 3,829
2018-10-24 Sherman Matthew L Director Grant or award · Stock Option (right to buy) +30,000 30,000
2018-10-24 Kiener Peter A Director Grant or award · Stock Option (right to buy) +30,000 30,000
2018-09-14 KIRITSY CHRISTOPHER P Director Purchase +5,000 $5.11 $26K 10,000
2018-07-25 Richman Michael Director Grant or award · Stock Option (right to buy) +2,837 $3.86 $11K 2,837
2018-05-15 GERAGHTY JAMES A Director Purchase +10,000 $5.75 $58K 20,000
2018-04-30 ORBIMED ADVISORS LLC 10% owner Sale −989,600 $6.35 $6.3M 4,511,130
2018-04-30 ORBIMED ADVISORS LLC 10% owner Sale −10,400 $6.35 $66K 38,870
2018-04-25 Richman Michael Director Grant or award · Stock Option (right to buy) +2,665 $4.10 $11K 2,665
2018-04-25 Barbier Ann Director Grant or award · Stock Option (right to buy) +30,000 30,000
2018-02-20 Matis Louis Chief Development Officer Grant or award · Stock Options (Right to buy) +100,000 100,000
2018-02-20 Reine Allan Chief Financial Officer Grant or award · Stock Options (Right to buy) +53,833 53,833
2018-02-20 Reine Allan Chief Financial Officer Grant or award · Stock Options (Right to buy) +50,000 50,000
2018-02-20 Yoder Stephen S. Chief Executive Officer Grant or award · Stock Options (Right to buy) +325,000 325,000
2018-02-13 ORBIMED ADVISORS LLC 10% owner Option exercise +6,057 $4.68 $28K 5,506,787
2018-02-13 ORBIMED ADVISORS LLC 10% owner Option exercise +58 $4.68 $271 49,328
2018-02-13 ORBIMED ADVISORS LLC 10% owner Option exercise +1,765 $5.08 $9K 5,508,552
2018-02-13 ORBIMED ADVISORS LLC 10% owner Option exercise +17 $5.08 $86 49,345

Page 15 of 21 · 412 trades